Switch to:
Also traded in: Germany, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.08
NYSE:PAH's Cash-to-Debt is ranked lower than
92% of the 1086 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.93 vs. NYSE:PAH: 0.08 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:PAH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.08  Med: 0.18 Max: N/A
Current: 0.08
Equity-to-Asset 0.27
NYSE:PAH's Equity-to-Asset is ranked lower than
88% of the 1047 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.56 vs. NYSE:PAH: 0.27 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:PAH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.21  Med: 0.25 Max: 0.54
Current: 0.27
0.21
0.54
Interest Coverage 0.67
NYSE:PAH's Interest Coverage is ranked lower than
96% of the 958 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 38.76 vs. NYSE:PAH: 0.67 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:PAH' s Interest Coverage Range Over the Past 10 Years
Min: 0.25  Med: 0.86 Max: N/A
Current: 0.67
Piotroski F-Score: 5
Altman Z-Score: 0.61
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 7.06
NYSE:PAH's Operating Margin % is ranked lower than
51% of the 1061 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.15 vs. NYSE:PAH: 7.06 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:PAH' s Operating Margin % Range Over the Past 10 Years
Min: 1.13  Med: 7.07 Max: 15.74
Current: 7.06
1.13
15.74
Net Margin % -2.05
NYSE:PAH's Net Margin % is ranked lower than
85% of the 1063 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.22 vs. NYSE:PAH: -2.05 )
Ranked among companies with meaningful Net Margin % only.
NYSE:PAH' s Net Margin % Range Over the Past 10 Years
Min: -12.14  Med: -2.06 Max: 6.29
Current: -2.05
-12.14
6.29
ROE % -1.64
NYSE:PAH's ROE % is ranked lower than
85% of the 1049 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.43 vs. NYSE:PAH: -1.64 )
Ranked among companies with meaningful ROE % only.
NYSE:PAH' s ROE % Range Over the Past 10 Years
Min: -15.04  Med: -7.61 Max: 1.03
Current: -1.64
-15.04
1.03
ROA % -0.70
NYSE:PAH's ROA % is ranked lower than
83% of the 1087 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.37 vs. NYSE:PAH: -0.70 )
Ranked among companies with meaningful ROA % only.
NYSE:PAH' s ROA % Range Over the Past 10 Years
Min: -4.19  Med: -0.81 Max: 7.46
Current: -0.7
-4.19
7.46
ROC (Joel Greenblatt) % 20.39
NYSE:PAH's ROC (Joel Greenblatt) % is ranked higher than
67% of the 1079 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 13.62 vs. NYSE:PAH: 20.39 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:PAH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.34  Med: 13.38 Max: 99.98
Current: 20.39
1.34
99.98
GuruFocus has detected 4 Warning Signs with Platform Specialty Products Corp $NYSE:PAH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:PAH's 10-Y Financials

Financials (Next Earnings Date: 2017-05-28 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

PAH Guru Trades in Q1 2016

Paul Singer 1,446,500 sh (New)
David Dreman 1,352 sh (New)
First Eagle Investment 57,800 sh (New)
John Griffin 12,785,000 sh (unchged)
Bill Ackman 42,737,394 sh (unchged)
Ron Baron Sold Out
Murray Stahl 3,915,356 sh (-3.72%)
» More
Q2 2016

PAH Guru Trades in Q2 2016

Mario Gabelli 20,000 sh (New)
RS Investment Management 15,010 sh (New)
John Griffin 12,785,000 sh (unchged)
David Dreman 1,352 sh (unchged)
Bill Ackman 42,737,394 sh (unchged)
First Eagle Investment Sold Out
Paul Singer Sold Out
Murray Stahl 3,707,185 sh (-5.32%)
» More
Q3 2016

PAH Guru Trades in Q3 2016

Jim Simons 187,100 sh (New)
Paul Tudor Jones 90,812 sh (New)
Larry Robbins 10,294,598 sh (New)
Mario Gabelli 47,000 sh (+135.00%)
John Griffin 12,785,000 sh (unchged)
Bill Ackman 42,737,394 sh (unchged)
David Dreman 1,352 sh (unchged)
Murray Stahl 3,482,334 sh (-6.07%)
» More
Q4 2016

PAH Guru Trades in Q4 2016

Paul Singer 10,951,281 sh (New)
Paul Tudor Jones 345,342 sh (+280.28%)
Larry Robbins 13,847,112 sh (+34.51%)
Mario Gabelli 60,000 sh (+27.66%)
Jim Simons 215,200 sh (+15.02%)
John Griffin 12,785,000 sh (unchged)
David Dreman 1,352 sh (unchged)
Bill Ackman 40,451,506 sh (-5.35%)
Murray Stahl 932,507 sh (-73.22%)
» More
» Details

Insider Trades

Latest Guru Trades with NYSE:PAH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Chemicals » Specialty Chemicals    NAICS: 325998    SIC: 2899
Compare:OTCPK:OCINY, OTCPK:TINLY, NYSE:CBT, NYSE:SXT, NYSE:GRA, NYSE:POL, OTCPK:OCLDY, NYSE:OLN, NYSE:FUL, NYSE:NGVT, NYSE:NEU, NYSE:GCP, OTCPK:KSANF, OTCPK:VTXPF, NYSE:KRO, NYSE:KWR, NYSE:SCL, NAS:IOSP, OTCPK:TYOBY, OTCPK:CLZNY » details
Traded in other countries:PLQ.Germany, PAH.UK,
Headquarter Location:USA
Platform Specialty Products Corp is a producer of high technology specialty chemical products and provider of post-sale technical services.

Platform Specialty Products Corp was incorporated under the laws of the British Virgin Islands on April 23, 2013. The Company's businesses include the manufacture of a broad range of specialty chemicals, which it create by blending raw materials, and the incorporation of these chemicals into multi-step technological processes. These specialty chemicals and processes together encompass the products and sells in the electronics, metal and plastic plating, graphic arts, and offshore oil production and drilling industries. The Company has two operating segments: Performance Solutions and Agricultural Solutions. The Performance Solutions segment formulates and markets dynamic chemistry solutions that are used in automotive production, commercial packaging and printing, electronics, and oil and gas production and drilling. Its products include surface and coating materials, functional conversion coatings, electronics assembly materials, water-based hydraulic control fluids and photopolymers. Within this segment, the Company provides specialty chemicals to the following industries, Electronics, Commercial Packing and Printing, Industrial, and Offshore. The Agricultural Solutions segment is based on a solutions-oriented business model that focuses on product innovation to address an ever-increasing need for higher crop yield and quality. It offers to growers diverse crop protection solutions from weeds (herbicides), insects (insecticides) and diseases (fungicides), in foliar and seed treatment applications. It also offers proven biosolutions, including biostimulants, nutrition and biocontrol products. It emphasize on farmer economics and food safety by combining, when possible, biosolutions with crop protection and seed treatment agrochemicals. The Company competes in markets for specialty chemicals for agrochemicals, electronic applications, general metal and plastic finishing, oil and gas exploration and production, and printing. The Company is subject to federal, state and local laws and regulations.

Top Ranked Articles about Platform Specialty Products Corp

Arysta LifeScience Announces Increase in R&D Pipeline Value

CARY, N.C., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Arysta LifeScience, a Platform Specialty Products company (NYSE:NYSE:PAH), announced today an increase in the value of its research and development (R&D) pipeline from the addition of seven active substances to its product development portfolio in the last 12 months. Five of them were obtained through in-licensing partnerships with other discovery-based companies. Considering all new products in development for launch from 2017 through 2025, Arysta LifeScience believes that, if successful, its pipeline of products could deliver a combined peak sales potential of up to $1.3 billion. In September, Platform Specialty Products hosted an Investor Day to present its strategy. During this event, Platform’s executive team described its strong focus on niche specialty segments and emphasized its pursuit of differentiation. “Innovation is the lifeblood of our strategy,” said Rakesh Sachdev, CEO of Platform Specialty Products. “Our ideation process starts with the customer, and our teams are focused on solving problems. We are excited with the progress of our R&D efforts in the Agricultural Solutions segment.” Despite challenging near-term market conditions in the agriculture industry, Arysta LifeScience’s leadership remains confident in its ability to continue to deliver sustainable growth. “We have a great innovation engine combined with excellent global market access in high-value niche segments of the industry,” said Diego Lopez Casanello, President of Arysta LifeScience. “This is why our partners entrust us with access to new active substances.” With the addition of these seven new active substances to the Arysta LifeScience product development portfolio, consisting of a herbicide, three insecticides, two fungicides and a novel biostimulant, Arysta LifeScience is nearing the end of the first phase of its pipeline renewal program. Included in this group, as previously announced, are a global collaboration with DuPont Crop Protection on the development of mixtures based on DuPont™ Rynaxypyr® insecticide, as well as an alliance with Beem Biologics to develop a new plant extract as a next generation of biostimulants. In addition, Arysta LifeScience is actively evaluating several earlier-stage compounds that it believes may have the potential to further increase its pipeline value by moving into full development phase during 2017.  Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of the federal securities laws, which include statements regarding Arysta LifeScience’s future annual sales, pipeline renewal program and further increase of its pipeline value. These statements are based on Arysta LifeScience management's estimates and assumptions with respect to future events and financial performance, and are believed to be reasonable, though are inherently difficult to predict.  Actual results could differ materially from those projected as a result of certain factors.  A discussion of factors that could cause results to vary is included in Platform's periodic and other reports filed with the Securities and Exchange Commission. Arysta LifeScience or Platform undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. About Arysta LifeScience Arysta LifeScience is a global agricultural company specializing in the marketing and distribution of innovative crop protection and life science brands. With more than 200 active ingredients, Arysta LifeScience has a well-integrated biological and chemical portfolio to provide complete solutions to growers. The company’s wide range of offerings includes biosolutions, fungicides, herbicides, insecticides and seed treatments. Arysta LifeScience, which has more than 3,000 employees working in 60 countries to serve customers worldwide, had 2016 revenues of US$1.8 billion. Arysta LifeScience is owned by Platform Specialty Products Corporation (NYSE:NYSE:PAH), a global innovator of technologically advanced specialty chemical products and provider of technical services (www.platformspecialtyproducts.com). For more information on Arysta LifeScience, visit www.arystalifescience.com.
Media Contact:
Carey Dorman
Director – Corporate Development
Platform Specialty Products Corporation
1 561-406-8465

Read more...
Platform Specialty Products Corporation to Present at Bank of America Merrill Lynch 2017 Global Agriculture and Chemicals Conference

WEST PALM BEACH, Fla., Feb. 24, 2017 (GLOBE NEWSWIRE) -- Platform Specialty Products Corporation (NYSE:NYSE:PAH)(“Platform”), a global specialty chemicals company, announced today that Benjamin Gliklich, Executive Vice President – Operations and Strategy, will be presenting at the Bank of America Merrill Lynch 2017 Global Agriculture and Chemicals Conference on Wednesday, March 1, 2017 at 10:00 am (Eastern Time).
A live webcast will be made available at the time of the presentation in the Investor Relations section of Platform's website at www.platformspecialtyproducts.com, where copies of the slides related to the presentation will also be provided. A replay of the webcast will be available for three weeks after completion of the presentation at www.platformspecialtyproducts.com. About Platform Platform is a global, diversified producer of high-technology specialty chemicals and a provider of technical services. The business involves the formulation of a broad range of solutions-oriented specialty chemicals, which are sold into multiple industries, including agricultural, animal health, electronics, graphic arts, plating, and offshore oil and gas production and drilling. More information on Platform is available at www.platformspecialtyproducts.com.
CONTACT:

Investor Relations Contact:

Carey Dorman
Director – Corporate Development
Platform Specialty Products Corporation
1-561-406-8465

Media Contact:

Liz Cohen
Weber Shandwick
1-212-445-8044

Read more...
Platform Specialty Products Corporation Announces Date for Release of Fourth Quarter and Full Year 2016 Financial Results

WEST PALM BEACH, Fla., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Platform Specialty Products Corporation (NYSE:NYSE:PAH) ("Platform") announced today that it intends to release its fourth quarter and full year 2016 financial results before the markets open on Tuesday, February 28, 2017.
Platform will host a webcast/dial-in conference call to discuss its financial results at 8:30 a.m. (Eastern Time) on Tuesday, February 28, 2017. Participants on the call will include Rakesh Sachdev, Chief Executive Officer; Sanjiv Khattri, Chief Financial Officer; and Benjamin Gliklich, Executive Vice President – Operations and Strategy. To listen to the call by telephone, please dial (855) 357-3116 (domestic) or (484) 365-2867 (international) and provide the Conference ID: 74692869. The call will be simultaneously webcast at www.platformspecialtyproducts.com. A replay of the call will be available for three weeks shortly after completion of the live call at www.platformspecialtyproducts.com. About Platform Platform is a global, diversified producer of high-technology specialty chemicals and a provider of technical services. The business involves the formulation of a broad range of solutions-oriented specialty chemicals, which are sold into multiple industries, including agricultural, animal health, electronics, graphic arts, plating, and offshore oil and gas production and drilling. More information on Platform is available at www.platformspecialtyproducts.com.
CONTACT:

Investor Relations Contact:

Carey Dorman
Director – Corporate Development
Platform Specialty Products Corporation
1-561-406-8465

Media Contact:

Liz Cohen
Weber Shandwick
1-212-445-8044

Read more...

Ratios

vs
industry
vs
history
Forward PE Ratio 21.32
PAH's Forward PE Ratio is ranked lower than
72% of the 201 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 18.35 vs. PAH: 21.32 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PB Ratio 1.06
PAH's PB Ratio is ranked higher than
77% of the 1048 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.99 vs. PAH: 1.06 )
Ranked among companies with meaningful PB Ratio only.
PAH' s PB Ratio Range Over the Past 10 Years
Min: 0.77  Med: 1.01 Max: 1.14
Current: 1.06
0.77
1.14
PS Ratio 0.73
PAH's PS Ratio is ranked higher than
72% of the 1035 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.34 vs. PAH: 0.73 )
Ranked among companies with meaningful PS Ratio only.
PAH' s PS Ratio Range Over the Past 10 Years
Min: 0.72  Med: 1.09 Max: 6.1
Current: 0.73
0.72
6.1
Price-to-Free-Cash-Flow 28.04
PAH's Price-to-Free-Cash-Flow is ranked lower than
74% of the 412 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 17.20 vs. PAH: 28.04 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
PAH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.71  Med: 18.81 Max: 58.76
Current: 28.04
7.71
58.76
Price-to-Operating-Cash-Flow 17.61
PAH's Price-to-Operating-Cash-Flow is ranked lower than
76% of the 493 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 10.40 vs. PAH: 17.61 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
PAH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.53  Med: 15.64 Max: 53.1
Current: 17.61
6.53
53.1
EV-to-EBIT 24.58
PAH's EV-to-EBIT is ranked lower than
72% of the 1124 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 16.80 vs. PAH: 24.58 )
Ranked among companies with meaningful EV-to-EBIT only.
PAH' s EV-to-EBIT Range Over the Past 10 Years
Min: 24.58  Med: 93.7 Max: 706.2
Current: 24.58
24.58
706.2
EV-to-EBITDA 14.56
PAH's EV-to-EBITDA is ranked lower than
60% of the 1142 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 12.25 vs. PAH: 14.56 )
Ranked among companies with meaningful EV-to-EBITDA only.
PAH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 14.56  Med: 46.1 Max: 706.2
Current: 14.56
14.56
706.2
Current Ratio 1.91
PAH's Current Ratio is ranked higher than
52% of the 957 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.86 vs. PAH: 1.91 )
Ranked among companies with meaningful Current Ratio only.
PAH' s Current Ratio Range Over the Past 10 Years
Min: 1.91  Med: 2.92 Max: 6.55
Current: 1.91
1.91
6.55
Quick Ratio 1.53
PAH's Quick Ratio is ranked higher than
58% of the 957 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.36 vs. PAH: 1.53 )
Ranked among companies with meaningful Quick Ratio only.
PAH' s Quick Ratio Range Over the Past 10 Years
Min: 1.53  Med: 2.33 Max: 5.69
Current: 1.53
1.53
5.69
Days Inventory 93.10
PAH's Days Inventory is ranked lower than
72% of the 1022 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 65.16 vs. PAH: 93.10 )
Ranked among companies with meaningful Days Inventory only.
PAH' s Days Inventory Range Over the Past 10 Years
Min: 36.92  Med: 80.2 Max: 120.72
Current: 93.1
36.92
120.72
Days Sales Outstanding 107.37
PAH's Days Sales Outstanding is ranked lower than
85% of the 858 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 59.97 vs. PAH: 107.37 )
Ranked among companies with meaningful Days Sales Outstanding only.
PAH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 69.37  Med: 124.53 Max: 146.87
Current: 107.37
69.37
146.87
Days Payable 67.37
PAH's Days Payable is ranked higher than
66% of the 814 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 49.46 vs. PAH: 67.37 )
Ranked among companies with meaningful Days Payable only.
PAH' s Days Payable Range Over the Past 10 Years
Min: 51.84  Med: 77.29 Max: 106.01
Current: 67.37
51.84
106.01

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -30.40
PAH's 3-Year Average Share Buyback Ratio is ranked lower than
93% of the 486 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -1.60 vs. PAH: -30.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PAH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -30.4  Med: 0 Max: 0
Current: -30.4
-30.4
0

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.67
PAH's Price-to-Median-PS-Value is ranked higher than
93% of the 952 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.32 vs. PAH: 0.67 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
PAH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.67  Med: 0.75 Max: 1.48
Current: 0.67
0.67
1.48
Earnings Yield (Greenblatt) % 4.07
PAH's Earnings Yield (Greenblatt) % is ranked lower than
61% of the 1290 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.25 vs. PAH: 4.07 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
PAH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.1  Med: 1.1 Max: 4.07
Current: 4.07
0.1
4.07

More Statistics

Revenue (TTM) (Mil) $3,586
EPS (TTM) $ -1.41
Beta3.32
Short Percentage of Float13.76%
52-Week Range $6.85 - 14.37
Shares Outstanding (Mil)285.68

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 3,706 3,844 3,989
EPS ($) 0.61 0.95 1.35
EPS without NRI ($) 0.61 0.95 1.35
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for NYSE:PAH

Headlines

Articles On GuruFocus.com
Platform Specialty Products Corporation Announces Date for Release of 2017 First Quarter Financial R Apr 26 2017 
Platform Specialty Products Corporation Completes Repricing of $1.93 Billion of Term Loans; Further Apr 18 2017 
Bill Ackman Comments on Platform Specialty Products Mar 30 2017 
Platform Specialty Products Corporation Announces Changes to Leadership Structure Mar 16 2017 
Platform Specialty Products Corporation to Present at the 29th Annual ROTH Conference Mar 07 2017 
Arysta LifeScience Announces Increase in R&D Pipeline Value Feb 28 2017 
Platform Specialty Products Corporation to Present at Bank of America Merrill Lynch 2017 Global Agr Feb 24 2017 
Platform Specialty Products Corporation Announces Date for Release of Fourth Quarter and Full Year 2 Feb 21 2017 
Bill Ackman Expands Chipotle Position, Cuts Zoetis Feb 15 2017 
Bill Ackman Comments on Platform Specialty Products Corp Dec 09 2016 

More From Other Websites
Platform Specialty Products Corporation Announces Date for Release of 2017 First Quarter Financial... Apr 26 2017
Platform Specialty Products Corp. – Value Analysis (NYSE:PAH) : April 21, 2017 Apr 21 2017
Platform Specialty Products Corp. breached its 50 day moving average in a Bullish Manner : PAH-US :... Apr 20 2017
Platform Specialty Products Corporation Completes Repricing of $1.93 Billion of Term Loans; Further... Apr 18 2017
Platform Specialty Products Corp. breached its 50 day moving average in a Bearish Manner : PAH-US :... Apr 06 2017
Platform Specialty Products Corporation -- Moody's says Platform's repricing transaction lowers... Mar 28 2017
Platform Specialty Products Corp. breached its 50 day moving average in a Bullish Manner : PAH-US :... Mar 23 2017
Platform Specialty Products Corporation Announces Changes to Leadership Structure Mar 16 2017
Platform Specialty Products Corporation to Present at the 29th Annual ROTH Conference Mar 07 2017
Cramer’s Exec Cut: 4 signs of global growth in the Trump ... Mar 03 2017
Platform Specialty Products: Cramer's Top Takeaways Mar 03 2017
Cramer Remix: Best investment trend in a changing economy Mar 02 2017
Platform Specialty Products Corp. :PAH-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2,... Mar 02 2017
Arysta LifeScience Announces Increase in R&D Pipeline Value Feb 28 2017
Edited Transcript of PAH earnings conference call or presentation 28-Feb-17 1:30pm GMT Feb 28 2017
Platform Specialty beats 4Q profit forecasts Feb 28 2017
Platform Specialty Products Corporation Announces 2016 Fourth Quarter and Full Year Financial... Feb 28 2017
Why Platform Specialty Products (PAH) Might Surprise This Earnings Season Feb 27 2017
Platform Specialty Products Corporation to Present at Bank of America Merrill Lynch 2017 Global... Feb 24 2017
Platform Specialty Products Corporation Announces Date for Release of Fourth Quarter and Full Year... Feb 21 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)